Announcement

Collapse
No announcement yet.

EDTA/Chelation and Toxic Metals

Collapse
X
  • Filter
  • Time
  • Show
Clear All
new posts

  • EDTA/Chelation and Toxic Metals

    I believe that you can, by taking some simple and inexpensive measures, extend your life and your years of well-being. My most important recommendation is that you take vitamins every day in optimum amounts, to supplement the vitamins you receive in your food."
    -Linus Pauling, Ph.D., Two-time Nobel Prize Laureate



    Chelation therapy is a safe and effective method for drawing toxins and metabolic wastes from the bloodstream. Chelating agents administered intravenously have been proven to increase blood flow and remove arterial plaque. Chelation therapy can help reverse atherosclerosis, can prevent heart attacks and strokes, and is used as an alternative to bypass surgery and angioplasty.



    Chelation (key-LAY-shun) comes from the Greek word chele meaning "to claw" or "to bind." Chelation therapy is used to rid the body of unnecessary and toxic metals, and is employed by a growing number of physicians to reverse the process of atherosclerosis (hardening of the arteries). The reversal is accomplished in part through the removal of the calcium content of plaque from the artery walls through the injection of chelating agents. By restoring good circulation to all the tissues of the body, chelation therapy can help to avoid bypass surgery, reverse gangrene, alleviate intermittent claudication (cramps) of the legs, and restore memory. Due to its ability to remove toxic metal ions, chelation therapy reduces internal inflammation caused by free radicals (highly reactive destructive molecules), and as a result can ease the discomfort and disability from degenerative diseases such as arthritis, scleroderma (a hardening that occurs in skin and certain organs), and lupus.

    Chelation therapy has been used safely on more than five hundred thousand patients in the United States for the past forty years,1 but EDTA (ethylenediaminetetraacetic acid), the drug used during the infusions, has yet to receive FDA (Food and Drug Administration) approval for anything other than lead and heavy metal toxicity. Still, there are over one thousand physicians who recommend and use chelation therapy for cardiovascular disease and related health problems. Following the treatment protocol set by the American College of Advancement in Medicine and the American Board of Chelation Therapy, FDA-approved studies are currently underway to establish the safety of EDTA.




    References

    1. Olszewer, E.; and Carter, J. P. "EDTA Chelation Therapy in Chronic Degenerative Disease." Medical Hypotheses 27 no. 1 (Sep, 1988): 41-49.



    Chelation therapy is performed on an out-patient basis, is painless, and takes approximately three and a half hours. For optimal results, physicians who use chelation therapy recommend twenty to thirty treatments given at an average rate of one to three per week, with patient evaluations being made at regular intervals.2




    Sites of atherosclerotic lesions in the body
    The patient reclines comfortably and is given an intravenous solution of EDTA with vitamins and minerals. To monitor the patient's progress, James Julian, M.D., of Los Angeles, recommends that the following tests be taken before, during, and after chelation:


    Blood pressure and circulation


    Cholesterol and other blood components


    Pre- and postvascular


    Blood sugar and nutritional


    Kidney and organ function


    Tissue minerals, if indicated

    A whole foods, low-fat diet, and appropriate exercise are normally recommended as part of a full treatment program. According to Garry Gordon, M.D., of Tempe, Arizona, a carefully tailored program of vitamin and nutritional supplements should also be part of the treatment, and can include ascorbic acid (vitamin C), heparin, selenium, chromium, copper, zinc, and manganese. Smoking is strongly discouraged, and alcohol should be consumed only in moderation. The cost per treatment can vary, depending in part on the nutritional ingredients the doctor may choose to use.




    References

    2. Cranton, E. M., M.D. "Protocol of the American College of Advancement in Medicine for the Safe and Effective Administration of Intravenous EDTA Chelation Therapy." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton, M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 269-305.
    Admin@ http://www.proactivehealthnet.com

    " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
    Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


    "The fact is that you can not start off with bad science and end up with good medicine"


  • #2
    "According to current drug safety standards, aspirin is about three and a half times more toxic than EDTA."



    By 1948 the U.S. Navy had begun using EDTA to safely and successfully treat lead poisoning. At the same time, EDTA was being used to remove calcium from pipes and boilers. Norman Clarke, Sr., M.D., Director of Research at Providence Hospital in Detroit, Michigan, hypothesized that because calcium plaque is a prominent component in atherosclerosis, EDTA would be an effective treatment for heart conditions. His experiments with EDTA chelation treatments for heart patients validated his theory. Patients with angina reported dramatic relief from chest pain. Healing was also reported by patients with gangrene. For many patients, memory, sight, hearing, and sense of smell improved, and most reported increased vigor.3

    EDTA chelation therapy has since proven to be safe and effective in the treatment and prevention of ailments linked to atherosclerosis such as coronary artery disease (heart attacks), cerebral vascular disease (stroke), peripheral vascular disease (leading to pain in the legs and ultimately gangrene and amputation), as well as arterial blockages from atherosclerosis elsewhere in the body. According to current drug safety standards, aspirin is nearly three and a half times more toxic than EDTA.4

    Warren Levin, M.D., of New York City, once administered chelation therapy to a psychoanalyst on the staff of a major New York medical center. "He was in his fifties and looked remarkably healthy, except that he was in a wheelchair. He had awakened that morning to discover his lower leg was cold, numb, mottled, and blue, with two black-looking toes. He rushed to his hospital and consulted the chief of vascular surgery, who recommended an immediate amputation above the knee. He asked this world-renowned surgeon about the possibility of using chelation in this situation, and was told, 'Don't bother me with that voodoo.'

    "The ailing man decided to get a second opinion. This physician also urged him to have an immediate amputation. When asked about chelation therapy, the second doctor's response was, 'You can try it if you want, but it's a waste of time.'

    "Through his own tenacity, the psychoanalyst showed up in my office. We started emergency chelation and after approximately nine treatments-one taken every other day-he was pain free and picking up. After approximately seventeen chelation treatments, he was walking on the leg again. He never had an amputation, and he lived the rest of his life without any further complications."

    Anecdotal stories of patient success tend to mean little to a medical researcher like Morton Walker, D.P.M. "But," he writes, "what must an investigative medical journalist do when exposed to story after story of potentially imminent death, blindness, amputation, paralysis, and other problems among people, and upon visiting those people to check their stories, finds them presently free of all signs of their former health problems? About two hundred individuals who were victims of hardening of the arteries are . . . [now] vibrant, productive, youthful looking, vigorous, full of zest, and enthusiastically endorse chelation therapy as the cause of their prolonged good health. I have turned up not a single untruth."9

    Medical journalists Harold and Arline Brecher, who have written extensively about chelation therapy, note that physicians who use it not only advise it for their patients, but use it for themselves, unlike many of their orthodox colleagues. "We have yet to find a physician who offers chelation to his patients who does not chelate himself, his family, and friends," they report.

    Chelation therapy could save billions of dollars each year by preventing unnecessary coronary bypass surgeries, angioplasties, and other expensive procedures related to vascular disorders.



    One study documented significant improvement in 99 percent of patients suffering from peripheral vascular disease and blocked arteries of the legs. Twenty-four percent of those patients with cerebrovascular and other degenerative cerebral diseases also showed marked improvement, with an additional 30 percent having good improvement. Overall, nearly 90 percent of all treated patients had marked or good improvement as a result of chelation therapy.10

    A double-blind study in 1989 revealed that every patient suffering from peripheral vascular disease who was treated with chelation therapy showed a statistically significant improvement after only ten treatments.11 In another study published in 1989, 88 percent of the patients receiving chelation therapy showed improvement in cerebrovascular blood flow.12

    Other documented benefits of chelation therapy include:


    Normalization of 50 percent of cardiac arrhythmias13


    Improved cerebrovascular arterial occlusion14


    Improved memory and concentration when diminished circulation is a cause15


    Improved vision (with vascular-related vision difficulties)16


    Significantly reduced cancer mortality rates (as a preventive)17


    Protection against iron poisoning and iron storage disease18


    Detoxification of snake and spider venoms19

    Research is needed to validate the effectiveness of chelation therapy in reversing atherosclerosis and related circulatory conditions. If approved by the FDA as a treatment for atherosclerosis, chelation therapy could save thousands of lives annually.



    According to Elmer Cranton, M.D., of Troutdale, Virginia, chelation therapy has a profound effect on overall health. "In my clinical experience there is no doubt that intravenous EDTA chelation therapy to some extent slows the aging process," says Dr. Cranton. "Allergies and chemical sensitivities also seem to improve somewhat due to a better functioning of the immune system. All types of arthritis and muscle and joint aches and pains seem to be more easily controlled after chelation, although it is not a cure. In most cases, the progression of Alzheimer's disease will be slowed, and in some cases the improvement is quite remarkable and the disease does not seem to progress. Macular degeneration, a major cause of visual loss in the elderly, is often improved and almost always arrested or slowed in its progression by chelation therapy."





    Chelation Therapy Versus Bypass Surgery and Angioplasty

    In 1988 nearly 1 million Americans died of cardiovascular disease, making it the number one killer in the United States. Each year nearly three hundred thousand bypass surgeries and two hundred-fifty thousand angioplasties are performed in the United States. Furthermore, nearly twenty thousand deaths occur each year as a result of these procedures.5

    In 1992, Nortin Hadler, M.D., Professor of Medicine at the University of North Carolina School of Medicine, wrote that none of the two hundred-fifty thousand balloon angioplasties performed the previous year could be justified, and that only 3 to 5 percent of the three hundred thousand coronary artery bypass surgeries done the same year were actually indicated. Yet a cost comparison study prepared for the Great Lakes Association of Clinical Medicine in 1993 estimated that $10 billion was spent in the United States in 1991 on bypass surgery alone.6 At a symposium of the American Heart Association, Henry McIntosh, M.D., stated that bypass surgery should be limited to patients with crippling angina who do not respond to more conservative treatment.7

    Chelation therapy offers a viable alternative. In a 1988 study of 2,870 cases, Efrain Olszewer, M.D., and James Carter, M.D., head of nutrition at the Department of Applied Health Science, School of Public Health and Tropical Medicine at Tulane University, documented that EDTA chelation therapy brought about significant improvement in 93.9 percent of patients suffering from ischemic heart disease (coronary artery blockage).8

    Elmer Cranton, M.D., of Troutdale, Virginia, estimates chelation therapy can help avoid bypass surgery in 85 percent of cases. He points out that during all the time that chelation therapy has been administered according to established protocol, not one serious side effect has been reported.







    References

    3. Farr, C. H., M.D.; White, R.; and Schachter, M., M.D. "Chronological History of EDTA Chelation Therapy." Presented to the American College of Advancement in Medicine, Houston, TX., May, 1993.

    4. Walker, M.; and Gordon, G. The Chelation Answer: How to Prevent Hardening of the Arteries and Rejuvenate Your Cardiovascular System. New York: M. Evans and Company, Inc., 1982.

    5. Strauts, Z., M.D. "Correspondence Re: Berkeley Wellness Letter and Chelation Therapy." Townsend Letter for Doctors 106 (May, 1992): 382-383.

    6. Chappel, T. L., M.D. "Preliminary Findings From the Meda Analysis Study of EDTA Chelation Therapy." From a paper presented at the American College of Advancement in Medicine meeting May 5-9, 1993, in Houston, TX.

    7. Walker, M.; and Gordon, G. The Chelation Answer. New York: M. Evans and Company, Inc., 1982, 175.

    8. Olszewer, E., M.D.; and Carter, J. P., M.D. "EDTA Chelation Therapy: A Retrospective Study of 2,870 Patients." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton, M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 183.

    9. Walker, M. Chelation Therapy. Stamford, CT: New Way of Life, Inc., 1984. Currently out of print.

    10. Olszewer, E., M.D.; and Carter, J. P., M.D. "EDTA Chelation Therapy: A Retrospective Study of 2,870 Patients." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton, M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 197-211.

    11. Olszewer, E., M.D.; and Carter, J. P., M.D. "EDTA Chelation Therapy: A Retrospective Study of 2,870 Patients." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 197-211.

    12. McDonagh, E. W.; Rudolph, C. J.; and Cheraskin, E., M.D. "An Oculocerebro-vasculometric Analysis of the Improvement in Arterial Stenosis Following EDTA Chelation Therapy." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton, M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 155-166.

    13. Alsleben, H. R., M.D.; and Shute, W. E., M.D. How to Survive the New Health Catastrophes. Anaheim, CA: Survival Publications, Inc., 1973.

    14. McDonagh, E. W.; Rudolph, C. J.; and Cheraskin, E., M.D. "An "oculocerebrovasculometric Analysis of the Improvement in Arterial Stenosis Following EDTA Chelation Therapy." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton, M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 155-166.

    15. Casdorph, H. R., M.D. "EDTA Chelation Therapy: Efficacy in Brain Disorders." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton, M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 131-153.

    16. Alsleben, H. R., M.D.; and Shute, W. E., M.D. How to Survive the New Health Catastrophes. Anaheim, CA: Survival Publications, Inc., 1973.

    17. Blumer, W., M.D.; and Cranton, E. M., M.D. "Ninety Percent Reduction in Cancer Mortality After Chelation Therapy with EDTA." In A Textbook on EDTA Chelation Therapy, ed. E. M. Cranton, M.D. Special Issue, Journal of Advancement in Medicine 2 Nos. 1-2, New York: Human Sciences Press, 1989, 183.

    18. Alsleben, H. R., M.D.; and Shute, W. E., M.D. How to Survive the New Health Catastrophes. Anaheim, CA: Survival Publications, Inc., 1973.

    19. Alsleben, H. R., M.D.; and Shute, W. E., M.D. How to Survive the New Health Catastrophes. Anaheim, CA: Survival Publications, Inc., 1973.
    Admin@ http://www.proactivehealthnet.com

    " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
    Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


    "The fact is that you can not start off with bad science and end up with good medicine"

    Comment


    • #3
      Chelation Therapy and Cancer

      Beginning in 1958 a lengthy study was conducted in Switzerland on 231 adults who lived near a well-traveled highway and had a higher rate of cancer mortality than other people of the same city who lived in traffic-free areas. The study group also suffered from a higher incidence of nervous disorders, headaches, fatigue, gastrointestinal disorders, depression, and substance abuse. The researchers suggested that their symptoms might be due to a higher level of exposure to lead from automobile exhausts. Then in 1961, 59 patients from this group received ten or more EDTA chelation treatments plus vitamins C and B1, while the remaining 172 members of the group were untreated and served as control subjects. An eighteen-year follow-up study of the group conducted by Walter Blumer, M.D., of Nestal, Switzerland, revealed that only one of the 59 treated patients died of cancer (1.7 percent) as compared to thirty deaths (17.6 percent) from cancer among the nontreated subjects. This is a 90 percent reduction of mortality from cancer. Dr. Blumer found that death from atherosclerosis was also reduced among the treated patients. His findings were based upon Swiss death certificates and statistical evidence showing that EDTA chelation therapy was the only significant difference between the control group and the treated patients.20

      Commenting on Dr. Blumer's study, Garry F. Gordon, M.D., of Tempe, Arizona, says, "Anything that reduces your burden of toxic metals, which feeds the fire of free radicals, sufficiently safeguards your immune system so that your body can more efficiently handle early cancers." Dr. Gordon prefers to view chelation therapy in terms of cancer prevention and not as a treatment in itself. "Cancer has been linked to free radical pathology and EDTA chelation removes elements, such as iron, which can accelerate this pathology," he says. "Therefore, chelation treatments can minimize one's risk of developing cancer."
      Admin@ http://www.proactivehealthnet.com

      " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
      Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


      "The fact is that you can not start off with bad science and end up with good medicine"

      Comment


      • #4
        SS-Note: DMPS is a Mercury Chelator, and can be found in health food stores and take orally-


        Mercury in our Environment



        Mercury and the environment-


        Our nation’s precious natural resources and our communities are being threatened by an imminent ecological calamity - mercury contamination of our air, soils and water is reaching epidemic proportions.


        • Today, over 12 million acres (30 percent) of our lakes and 453 thousand miles of our rivers are subject to state-issued mercury fish advisories – with fish too contaminated for safe consumption by many members of our communities, including pregnant women and young children.


        • Currently, 45 states have mercury-contamination advisories in effect for fish, compared with only 27 states a decade ago.


        • A recent study for the Centers for Disease Control and Prevention (CDC) indicates that 8 percent of women in the United States have mercury levels considered unsafe, putting more than 630,000 American children born each year at “higher risk of adverse health effects” due to mercury exposure.



        Mercury and cardiovascular disease

        Until recently, the notion of treating heart disease with chelation therapy—one of the mechanisms of which is to remove heavy metals—was scorned by the medical establishment. But it appears that, once again, the field of “alternative medicine” has been ahead of its time. In an article in the November 28th, 2002 issue of the New England Journal of Medicine, “Mercury, fish oils, and the risks of myocardial infarction,” the authors stated:



        “Mercury may promote atherosclerosis and hence increase the risk of myocardial infarction in several ways. Mercury promotes the production of free radicals…and may bind selenium [so that it] cannot serve as a cofactor for glutathione peroxidase. Mercury may…inactivate the antioxidant properties of glutathione, catalase, and superoxide dismutase. Mercury may induce lipid peroxidation, and mercury levels were a strong predictor of oxidized LDL levels…Mercury compounds can also promote platelet aggregability and blood coagulability, inhibit endothelial-cell formation and migration, and affect apoptosis and the inflammatory response. Increased rates of cardiovascular disease were found in mercury-exposed workers, and mercury levels in hair predicted the progression of carotid atherosclerosis in a longitudinal study.” 10



        The article found that mercury levels were directly associated with the risk of myocardial infarction (heart attacks), and that this partially offset the protective effects of DHA derived from eating fish. The New England Journal editorialized: “The notion that methylmercury contributes to cardiovascular disease is certainly a testable hypothesis and one that warrants further testing.” 11



        Studies document high mercury exposures from dental amalgam fillings and fish and common adverse neurological and cardiovascular effects.

        The largest source of mercury in most people is from dental amalgam fillings and exposures are commonly more than the federal health guideline for mercury due to mercury's high volatilization rate at room temperature and oral galvanism and EMF effects on mixed metals in the mouth. 12
        Approximately 50 percent of Florida lakes and rivers have fish consumption warnings due to high mercury levels and 20 % of all U.S. lakes have similar warnings. The majority of Gulf Coast saltwater predator fish species have levels of mercury documented to cause adverse effects. The majority who eat such fish at least once per week have been found to have dangerous levels of mercury. 13
        Dental amalgam is a larger source of methyl mercury than fish in many people, due to the high exposure from dental fillings and the methylation of elemental and inorganic mercury to methyl mercury by bacteria and other means in the body. Mercury exposures are cumulative and also synergistic with other toxic metals and other toxic substances for which exposures are common. 14, 15
        Infants usually get higher mercury exposures than their mother's from prenatal exposures across the placenta from their mother and from breast milk. Mom's dental amalgam, fish, and mercury Thimerasol used in vaccines are all significant sources of exposure for the fetus and infants. Mercury and other toxic metal exposures are the most common cause of children's neurological conditions like autism, ADHD, dyslexia, excema, etc. that have been rapidly increasing over the last decade. 16,17
        Studies have documented the mechanisms by which mercury commonly causes neurological and autoimmune conditions. Mercury has been shown to be highly cytotoxic, neurotoxic, and immunotoxic. Mercury has been found to bioaccumulate in the brain, central nervous system(CNS), heart, and hormonal glands and cause damage to nerve cells, blood cells, DNA, etc. and to block the function of the hormonal system and enzymatic processes of the body's cellular metabolic system. 18,19,20,21
        Medical studies have documented that mercury accumulates in the heart and has common adverse effects on the cardiovascular and circulatory system. 22
        “Silver”/Mercury Dental Fillings Facts:



        Silver or amalgam dental fillings contain from 48-55 percent mercury, 33-35 percent silver, and various amounts of copper, tin and other metals. Since mercury is the major component of the material, any representation of the material should include the word “mercury”.



        Mercury is a powerful poison. Published research has shown that mercury is more toxic than lead, cadmium and even arsenic. Furthermore, there is no known toxic threshold for mercury vapor and world renowned mercury toxicologists have stated that no amount of exposure to mercury vapor can be considered totally harmless.



        Scientific research has demonstrated that mercury, even in small amounts, can damage the brain, heart, lungs, liver, kidneys, thyroid gland, pituitary gland, adrenal gland, blood cells, enzymes and hormones, and suppress the body’s immune system. Mercury has been shown to pass the placental membrane in pregnant women and cause permanent damage to the brain of the developing baby.



        Mercury is continually released from mercury dental filings in the form of mercury vapor and abraded particles. This process is stimulated and can be increased as much as 15-fold by chewing, brushing, hot liquids, etc. The World Health Organization recently concluded that the daily intake of mercury from amalgam dental fillings exceeded the combined daily intake of mercury derived from air, water and food (including fish).

        The mercury vapor released from mercury dental filings is absorbed very rapidly and thoroughly in your body primarily by inhalation and swallowing.



        In human autopsy studies, it has been determined that there is a direct correlation between the amount of mercury found in the brain and the number of surfaces of mercury fillings in the teeth.



        Mercury causes normal intestinal microflora to become mercury resistant and antibiotic resistant. Mercury resistant bacteria cause mercury in the intestinal tract to be converted back into vapor and recycled back into the body. Antibiotic resistance is becoming a major medical concern.



        Recent scientific research has shown high levels of mercury in the brains of individuals dead from Alzheimer’s disease (AD). Other research is demonstrating mercury can cause similar pathological effects in the brain as that seen in Lou Gehrig’s disease (ALS) and AD. Laboratory studies of spinal fluid from ALS and AD patient’s has confirmed that mercury inhibits key brain detoxification enzyme systems.


        Summary of recent Mercury poisoning research

        Mercury linked to heart disease
        ROME, ITALY. Medical researchers at the Catholic University in Rome report that patients with congestive heart failure (idiopathic dilated cardiomyopathy or IDCM) have vastly elevated concentrations of mercury and antimony in their heart tissue. They compared trace element concentrations in biopsy samples from the left ventricle among patients with IDCM and patients with valvular disorders or no heart disease at all. The IDCM patients had mercury concentrations 22,000 times higher than in the controls. Antimony concentrations were 12,000 times higher and silver, gold, chromium and arsenic levels were also highly elevated. Holter monitoring revealed frequent ectopic (premature) beats in all the IDCM patients and ventricular tachycardias in six of the 13 patients. None of the patients had had occupational exposure to the trace elements. Researchers at the University of Calgary point out that dental amalgams would be the most likely source of the mercury.
        Frustaci, Andrea, et al. Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction. Journal of the American College of Cardiology, Vol. 33, May 1999, pp. 1578-83 [32 references]
        Lorscheider, Fritz and Vimy, Murray. Mercury and idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, Vol. 35, March 1, 2000, p. 819 (letter to the editor)



        Trigeminal neuralgia linked to amalgam fillings
        JACKSONVILLE, FLORIDA. Dr. William Cheshire, a physician at the Mayo Clinic, reports on a case where a woman's trigeminal neuralgia (tic douloureux) was traced to a galvanic reaction between an amalgam filling and an adjacent gold-alloy crown. Consumption of tomatoes and other acidic foods produced intense jolts described as being like those of an "electrical battery". The jolts in turn resulted in excruciating pain in the trigeminal nerve. Replacing the amalgam filling with a composite resolved the problem. Dr. Cheshire points out that dissimilar metals in contact with saliva can form a galvanic cell which can generate electrical currents with several hundred millivolts of potential. He points out that many patients with trigeminal neuralgia describe their pain in terms of "electrical" jolts and concludes that his patient's neuralgia may well have been triggered by the galvanic reaction between the amalgam filling and the gold crown.
        Cheshire, William P., Jr. The shocking tooth about trigeminal neuralgia. New England Journal of Medicine, Vol. 342, June 29, 2000, p. 2003 (correspondence)



        Dental alloys affect cellular energy production
        NOTE: We usually do not report test tube or animal experiments, but thought we would make an exception in this case. The findings that commonly used dental alloys may interrupt the normal function of human cells is a first and could have wide-ranging effects.



        BIRMINGHAM, ALABAMA. Although nickel is known to be carcinogenic in humans it is still widely used in certain dental alloys. Researchers at the University of Alabama now report that other components of dental alloys (beryllium, chromium, and molybdenum) as well as nickel affect the very basic function of human cells - the production of energy (ATP). ATP is produced in the mitochondria of cells and involves highly oxidative processes. It is becoming increasingly clear that abnormalities in the mitochondrial processes are important causes of human disease. Some researchers believe that a slowing down of these processes actually heralds the very first stage in the proliferation of abnormal cells and cancer.


        The Alabama researchers exposed cultures of human gingival (gum) cells to solutions of nickel, beryllium, chromium (tri- and hexavalent) and molybdenum (hexavalent) for periods of 24 and 72 hours. They then measured the energy production and oxygen consumption of the cells' mitochondria in the various solutions. Cells in contact with nickel or hexavalent chromium were most affected and showed decreased ATP (energy) production as well as a decrease in oxygen consumption. The effects of beryllium, molybdenum, and trivalent chromium were similar, but less pronounced. The researchers conclude that their findings may be the first indication that some components of common dental alloys may be detrimental to human health. They urge further research to establish possible synergisms between mixtures of these different metals on mitochondrial energy production. [54 references]
        Messer, R.L.W., et al. An investigation of fibroblast mitochondria enzyme activity and respiration in response to metallic ions released from dental alloys. J Biomed Mater Res, Vol. 50, 2000, pp. 598- 604



        Dental amalgams come under fire - again!
        TAURANGA, NEW ZEALAND. The New Zealand Ministry of Health is reviewing its policy on the use of mercury-containing amalgams for tooth fillings. This review comes hard on the heels of a precautionary advice from the UK Department of Health which warns pregnant women not to have amalgam fillings installed. Dr. Mike Godfrey, a leading environmental physician, points out that several major amalgam manufacturers have issued Material Safety Data Sheets and Directions for Use which clearly warns of the many dangers of amalgam fillings. Among the restrictions - amalgam fillings should not be used next to fillings or crowns containing other metals, they should not be used under crowns, they should not be used in patients with kidney disease, in pregnant women or in children aged six years or younger. The manufacturers also warn that mercury vapours from amalgam fillings can induce psychiatric symptoms in extremely low concentrations. Depression, mental deterioration, and irritability are among the symptoms listed. Amalagam fillings are banned in Sweden and Health Canada has proposed a limit of one (two surfaces) amalgam fillings in a child and four (eight surfaces) in an adult. Dr. Godfrey points out that his chronic fatigue syndrome patients have an average of 15 amalgam fillings each and exhibit many of the symptoms that the amalgam manufacturers are warning against.
        Godfrey, M.E. and Feek, Colin. Dental amalgam. New Zealand Medical Journal, Vol. 111, August 28, 1998, p. 326 (letters to the editor)



        Depression and amalgam fillings
        FORT COLLINS, COLORADO. There is some evidence that people with dental amalgam fillings are more likely to suffer from depression than are people without such fillings. Now researchers at the Rocky Mountain Research Institute report that removal of amalgam fillings can markedly improve the symptoms of manic-depressive illness (bipolar disorder). Their study involved 20 patients who had been diagnosed with manic-depressive illness. All the patients had amalgam fillings (an average of 10 fillings each). The concentration of mercury in the mouth was measured at the start of the study and was found to increase almost 300 per cent after chewing gum for 10 minutes. Other research has shown that 75 per cent or more of the mercury vapor released by chewing is inhaled into the lungs where it enters the blood stream and subsequently passes into the brain. Eleven of the patients were assigned to have all their mercury fillings removed and were also given multi-vitamins and antioxidants to help chelate and remove the mercury released during the dental work. The remaining nine patients had a sealant placed over their fillings and were told that this sealant would prevent mercury from being released from their fillings. In actual fact there was no evidence that it would do so. The control group patients were given a supplemental vitamin and mineral tablet. The patients all completed various questionnaires designed to evaluate their mental health before and six to eight months after treatment. It was very clear that the patients who had had their amalgam fillings removed had improved very significantly in such important parameters as anxiety, depression, paranoia, hostility, and obsessive compulsive behaviour. Some of the patients were able to discontinue their lithium medication after amalgam removal. The researchers caution that their study was relatively small and urge large scale clinical trials to validate their findings.
        Siblerud, Robert L., et al. Psychometric evidence that dental amalgam mercury may be an etiological factor in manic depression. Journal of Orthomolecular Medicine, Vol. 13, No. 1, First Quarter 1998, pp. 31- 40



        Amalgam fillings may damage kidneys.
        NEWSBRIEF. Amalgam fillings and skin-lightening creams both contain significant amounts of mercury. Researchers at the King Faisal Hospital in Riyadh, Saudi Arabia have just completed a study aimed at determining whether the mercury actually gets into the blood stream. The study involved 225 women (aged 17 to 58 years) who had their urine measured for mercury, creatinine, urea, uric acid, phosphorus, magnesium, calcium, and glucose. The urinary mercury level varied between 0 and 204.8 micrograms per liter and was directly related to the number of dental amalgam fillings present in the women's mouths. The researchers conclude that chronic exposure to mercury may be associated with deterioration of renal (kidney) function.
        Biometals, Vol. 10, October 1997, pp. 315-23



        Amalgam fillings and hearing loss
        FORT COLLINS, COLORADO. The leaching of toxic mercury from amalgam fillings has been implicated in hearing loss. Mercury toxicity has also been linked to multiple sclerosis (MS). It is believed that the toxic effects of mercury cause damage to the blood brain barrier, demyelination (damage to the nerves' myelin sheaths) and slowing of the nerve conduction velocity. Now researchers at the Rocky Mountain Research Institute provide convincing proof that dental amalgam fillings may be responsible for the hearing loss often experienced by multiple sclerosis patients. Their experiment involved seven women aged 32-46 years who had been diagnosed with MS. The women underwent a standard hearing test in a sound booth and then had all their amalgam fillings replaced with composites. Six to eight months later they were again given the hearing test. Six of the seven patients had significantly improved hearing in the right ear and five of the seven showed improvement in the left ear. Overall, hearing improved an average of eight decibels. The researchers conclude that amalgam fillings may be a significant factor in hearing loss experienced by MS patients and could be a factor in hearing loss in other people as well.
        Siblerud, Robert L. and Kienholz, Eldon. Evidence that mercury from dental amalgam may cause hearing loss in multiple sclerosis patients. Journal of Orthomolecular Medicine, Vol. 12, No. 4, Fourth Quarter, 1997, pp. 240-44



        Chronic mercury poisoning is widespread
        HILLEROED, DENMARK. A Danish dentist, Dr. H. Lichtenberg, reports that most of his patients with amalgam fillings suffer from chronic mercury poisoning. Dr. Lichtenberg measured the actual concentration of mercury vapour in the mouths of his patients and found that it varied between 3 micrograms of mercury vapour per cubic meter of air and 329 mcg/m3 with an average of 54.6 mcg/m3. This compares to a maximum permitted level in the workplace of 50 mcg/m3 for people working eight hours a day five days a week. NOTE: This level applies to Denmark; the maximum level permitted in Switzerland is 10 mcg/m3 and in the USA it is 100 mcg/m3. A recent conference in Canada proposed a Tolerable Daily Intake (TDI) for mercury vapour of 0.014 mcg/kg of body weight per day; this corresponds to a maximum tolerable daily intake of 1.0 mcg for a person weighing 70 kilograms. Most of Dr. Lichtenberg's patients were thus exposed to 50 times the TDI. More than half of Dr. Lichtenberg's patients exhibited one or more of the following symptoms of chronic mercury poisoning - fatigue, poor concentration, poor memory, bloating, joint pain, muscle fatigue, cold hands and feet, irritability, and headache. Mercury poisoning from dental fillings has also been implicated in Alzheimer's disease and heart disease.
        Lichtenberg, H. Mercury vapour in the oral cavity in relation to number of amalgam surfaces and the classic symptoms of chronic mercury poisoning. Journal of Orthomolecular Medicine, Vol. 11, No. 2, Second Quarter 1996, pp. 87-94



        Mercury linked to heart disease
        HELSINKI, FINLAND. Researchers at the University of Kuopio in Finland have just completed a major study which clearly implicates mercury as a major cause of heart attacks and other coronary and cardiovascular diseases. The researchers set out to discover why men in Eastern Finland who eat lots of locally caught fish have an exceptionally high mortality from cardiovascular disease. Their conclusion was that the non-fatty freshwater fish eaten in Eastern Finland contains large amounts of mercury. The researchers discovered that men who had a high fish consumption not only had a high mercury content in their hair and urine, but also had a two-fold higher risk of having a heart attack and a three-fold higher risk of dying from heart disease than did men with a lower content of mercury in their hair. Men who ate fatty, ocean-caught fish such as salmon, herring, and tuna did not have an increased level of mercury in their hair. The researchers believe that mercury promotes heart disease in several ways: mercury promotes free radical generation; it inactivates the body's natural antioxidant glutathione; and it binds with selenium thus making it unavailable as an antioxidant and component of glutathione peroxidase. All these mechanisms would lead to an increased level of lipid peroxidation and subsequent heart disease. The researchers also point out that earlier studies have discovered a clear correlation between the number of amalgam tooth fillings and the risk of heart attack. Selenium and vitamin E have both been found to have a protective effect against mercury toxicity.
        Salonen, Jukka T. et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in Eastern Finnish men. Circulation, Vol. 91, No. 3, February 1, 1995, pp. 645-55


        LONDON, ENGLAND. Lord Baldwin, joint chairman of the British Parliamentary Group for Alternative and Complementary Medicine, is questioning the safety of amalgam dental fillings. In a letter published in the British Medical Journal Lord Baldwin asserts that it is up to the dental profession to prove that amalgam fillings are safe and, in Lord Baldwin's opinion, this they have not done. To point to the fact that amalgam fillings have been used for a hundred years is not a proof of safety anymore than it is to claim that tobacco smoking must be safe because people have been doing it for a long time, says Lord Baldwin.
        Baldwin, E.A.A. Controlled trials of dental amalgam are needed. British Medical Journal, Vol. 309, October 29, 1994, p. 1161



        For many years the ADA maintained that mercury did not escape from the amalgam fillings. That view began to change in 1981 when Dr. C. W. Svare reported his study in The Journal of the American Dental Association showing that mercury vapor definitely does penetrate the saliva covering the teeth. The April 1994 issue of JADA states:

        "Dental amalgam can release minute amounts of elemental mercury, a heavy metal whose toxicity at high exposure levels is well established."



        Prosthodontist Dr. David Eggleston notes various studies proving mercury amalgam does accumulate in the blood, breath, kidney and brain. He studied 83 age-matched cadavers from the Los Angeles morgue and found three times the level of mercury in the brains of those with mercury fillings as in those without. The only question is whether those levels are high enough to produce mercury poisoning.


        Among the most interesting research proving that mercury definitely escapes from your dental amalgams, is that done in Sweden by corrosion chemist, Jaro Pleva, Ph.D. Using a scanning electron microscope Dr. Pleva found that a five year-old amalgam filling contained only 27% mercury, as compared with its original content of 50%. Therefore, nearly one-half the mercury escaped the filling going into the body of the patient!



        Methyl mercury problems

        While elemental mercury is dangerous, methyl mercury is 100 times more toxic to the nervous system and 1000 times more toxic in producing genetic damage. Bacterial action in the mouth from Streptococcus mutans, a common bacteria in the mouth believed to cause dental decay, can react with amalgam fillings producing methyl mercury. Perhaps more significantly, this "methylating" of mercury from dental fillings appears to "program" the body to hang on to mercury from other sources, such as seafood, paint, cosmetics, and other environmental sources.



        Your mouth, the only safe place?

        Government agencies like OSHA and EPA regard mercury as toxic in the dental office both before it's placed in a patient's mouth and after it's removed from a patient's mouth. For example, if OSHA detected readings of more than 50 mcg/M3 of mercury in a dental office, they would close the office immediately and levy a $10,000 fine. After removal, strict disposal procedures must be followed to keep from violating environmental laws. So mercury is toxic before it's in your mouth and after it's removed from your mouth. The ADA wants you to believe that the only safe place for mercury is in your mouth.



        Industrialization


        Heavy metal exposure is implicated in a variety of central nervous system disorders, including Multiple Sclerosis, Parkinson’s, and Alzheimer’s disease. New research reveals its effects on cardiovascular disease and immune disorders. While mercury amalgam fillings are the most common source of inorganic mercury exposure, ongoing research in this field indicates that the problem is much more pervasive than initially thought. After most people conduct a urine analysis showing the presence of heavy metals, most people often ask where they might have been exposed to toxic metals. We now know that there are innumerable sources of heavy metals in the environment, and the problem appears to be increasing.



        Twentieth century industrialization has led to an increased exposure to heavy metals for everyone. Certain people risk increased exposure because of where they live, their occupation, or their lifestyle. Others may be genetically predisposed to heavy metal accumulation due to poor detoxification systems in their bodies. For these reasons, people in the same household may have vastly different rates of heavy metal accumulation in their bodies.



        Heavy metals occur in a variety of household sources. Paint can contain lead, mercury cadmium and antimony. Exposure occurs during the stripping of old paint. Many babies have been exposed to lead in older houses by chewing on painted surfaces.

        Insecticides and fungicides may contain arsenic, antimony and cadmium. Rat poisons often contain salt of thallium. Thallium is a bluish-white metal that enters the atmosphere through coal plants, smelters and mining. It enters the food chain through plants and can also be present in fish and shellfish. Thallium accumulates in the body with age and has been implicated in heart and nervous system disorders.

        Cooking utensils, such as pots and pans, contain both aluminum and copper. Household disinfectants may contain mercury, copper and silver. The preservatives in treated wood contain arsenic and copper.



        Vaccines given to children and adults contain mercury and aluminum. Babies are especially susceptible to small amounts of mercury injected directly into their tiny bodies. It is now suspected that the increase in autism and Asperger’s Syndrome is related to the mercury in childhood vaccinations.



        A surprising source of toxic exposure has been revealed to be the sheepskin bedding used as mattress covers by both adults and babies. Sudden Infant Death Syndrome is four times higher in New Zealand, where the use of sheepskin mattress covers is common. The body heat of the baby increases the growth of mould in the sheepskin, as well as the release of toxic gasses from arsenic and antimony, which bio-accumulate in sheep. Arsenic and antimony are insecticides in wide use throughout New Zealand.

        On the industrial side, automobiles release both manganese and cadmium from the catalytic converter and from tires. Diesel exhaust contains high amounts of nickel and sulfur in the form of sulfur dioxide. Power plants, especially coal-burning plants, release mercury, antimony, arsenic and thallium into the atmosphere. Steel and metal foundries release a variety of toxic metals including lead, arsenic, copper, aluminum, thallium, cobalt and antimony, into the atmosphere.



        Sewage sludge contains mercury, cadmium, lead and arsenic. Human bodies are a source of heavy metals, which are excreted into the bile and eliminated through the stool. Contaminated wastewater from industry is another common source of heavy metals ending up in sewage. Sewage is then either burned into the atmosphere or spread back onto the land as “organic fertilizer.”






        Heavy metal exposure also increases the risk of cardiovascular disease. When lead or other heavy metals enter the endothelial cells that line the interior of blood vessels, they interfere with the ability of these cells to produce the extremely important messenger molecule, nitric oxide (NO). Release of NO tells blood vessels when to relax and to expand, a primary mechanism in the control of blood pressure. Interference with this function by lead can result in hypertension (high blood pressure). It has also been linked to high cholesterol levels, atherosclerosis, diabetes, thrombus (blood clot) formation, and heart failure. This is why it’s imperative to reduce our exposure to heavy metals and remove what’s already in our bodies.
        Admin@ http://www.proactivehealthnet.com

        " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
        Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


        "The fact is that you can not start off with bad science and end up with good medicine"

        Comment


        • #5
          Fertilizer companies commonly buy industrial wastes as a cheap source of zinc and iron. These wastes frequently contain arsenic, lead, mercury and cadmium, as well as the highly toxic dioxins. These are then sold as fertilizers that are used in production of the commercial food supply. The California Department of Food and Agriculture predicts that food grown with contaminated fertilizers will be the greatest source of industrial toxin exposure to people, resulting in adverse health effects. This alone is a good reason to buy organic food as much as possible.



          Organic mercury, known as methyl mercury is extremely toxic. Unfortunately, fish is becoming a significant source of methyl mercury. Not all fish is loaded with methyl mercury. Fish caught in polluted water is obviously going to be higher in methyl mercury. Also, larger fish that eat smaller fish will have concentrated amounts of mercury in their flesh. Large saltwater fish, such as tuna, swordfish, shark, marlin, sea bass and halibut, should be eaten in limited quantities. Freshwater fish such as pike, walleye, largemouth bass and white croaker also contain high amounts of mercury, and intake should be avoided or limited. The American FDA has put out an advisory that children and pregnant women are not to eat shark, swordfish, tilefish or king mackerel because of the risk of neurological damage from methyl mercury.

          Unfortunately, exposure to toxic metal and chemical contamination of our bodies is universal and unavoidable. We are all subjected to some level of exposure depending on where we live.

          Heavy metal exposure is implicated in a variety of central nervous system disorders, including Multiple Sclerosis, Parkinson’s, and Alzheimer’s disease. New research reveals its effects on cardiovascular disease and immune disorders.

          Exposure to toxic metals has also been linked to immune system deficits, which lead to chronic infections, increased autoimmune reactions, and the growth of cancerous cells. High levels of metals such as mercury, lead, cadmium, and arsenic have been linked to decreased number and activity of white blood cells. This limits resistance to viruses, bacteria, fungi, and parasites.
          Admin@ http://www.proactivehealthnet.com

          " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
          Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


          "The fact is that you can not start off with bad science and end up with good medicine"

          Comment


          • #6
            Osteoporosis and Lead Toxicities

            SS note-EDTA is a very effective chelator of lead in the bloodstream-



            Lead toxicity is more common than you may think. Here is a small example of the latest research on lead and osteoporosis


            1: J Am Geriatr Soc. 2000 Nov;48(11):1501-6


            Lead toxicity in older adults.
            Vig EK, Hu H.

            Department of Medicine, University of Washington, Seattle, USA.

            Recent studies have shown that lead, even at relatively low levels of exposure, has the potential to harm not only the young and the occupationally-exposed, but also older people. Because they have been alive for a longer period of time, older adults have had more potential exposures to lead. They may have been exposed to lead while working in unregulated occupations, or they may have encountered more lead in the environment on a daily basis. Several large epidemiological studies have found that older people have higher blood and bone lead levels than younger adults. Additionally, sporadic clusters of acute lead exposure among older adults as a result of activities such as ceramic glaze hobby work and consumption of moonshine whiskey continue to be reported. After lead enters the body, it circulates in the blood reaching the soft tissues and bone. Researchers have learned that lead can hibernate within bone for decades. Although lead within bone is of uncertain toxicity to bone tissue, conditions of bone resorption, such as osteoporosis, can cause bone lead to reenter the bloodstream where it can then re-expose the soft tissue, and, potentially, exert delayed deleterious effects. Evidence is emerging that blood and bone lead levels, reflecting relatively modest exposures, are associated with hypertension, renal insufficiency, and cognitive impairment. Medical treatments that now exist to slow the rate of bone resorption may maintain lead within bones. On-going studies evaluating the relationship between body lead stores and both cognitive and renal impairment, as well as the potential modifying effect of bone resorption, will help determine whether bone resorption should be retarded specifically to preserve organ function. Physicians should be aware of potential past and present lead exposures among their older patients. Ongoing lead exposure should be prevented. In the future, treatment of osteoporosis may be undertaken not only to improve bone health but also to prevent mobilization of bone lead stores and subsequent toxicity.
            PMID: 11083332 [PubMed - indexed for MEDLINE]
            Admin@ http://www.proactivehealthnet.com

            " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
            Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


            "The fact is that you can not start off with bad science and end up with good medicine"

            Comment


            • #7
              EDTA is an effective chelator for lead in the bloodstream-


              Heavy metals affect three main areas of the human body: the nervous system, the cardiovascular system and the immune system. Heavy metals, such as mercury and lead, disrupt nerve cell growth and metabolism. They have been implicated in a variety of nervous system disorders. Recently, it has been discovered that mercury is elevated in the brains of Alzheimer patients. Previously, it was thought that aluminum caused the brain lesions associated with Alzheimer’s, but it now appears that mercury may be the main neurotoxin.



              Recent published research on Finnish men has demonstrated a two- to three-fold increased risk for heart attack and cardiovascular disease linked to the mercury in fish. Other research has found an extremely high concentration of mercury and antimony in diseased heart tissue. It appears that heavy metals accumulating in extremely high concentrations in heart muscle may lead to heart failure and electrical instability.

              Studies conducted at the National Academy of Science show clear and present danger of heavy metals in our bodies. Sixty-thousand children born each year may be affected by mercury toxicity. Tuna and dental fillings, as well as vaccinations with mercury can cause problems including birth defects, brain damage, depression, fatigue, hearing loss, vision loss, kidney damage and many more ailments.



              Lead levels in our bodies are 1000 times higher today than in our deceased ancestors 300 years ago! Those of us that have been alive for a while remember lead in our paint, our gasoline, and even canned foods. We can associate lead poisoning with pain, ADD, allergies, arthritis, seizures, Parkinson’s disease and other serious medical problems.

              The really bad news is that, according to the Environmental Protection Agency (EPA), 99% of our population contains chemicals that are linked to the development of cancer. Most heavy metals are carcinogenic and all can cause Free Radical Damage. They can cause the energy factories in our cells, known as mitochondria, to stop working which essentially causes cells to die. In the process, the DNA for those affected cells may also be damaged, causing a malfunction in the next generation of cells of this type. When the cells are programmed to die off quicker or to wildly multiply, we see problems such as weaker tissue, maligned function or tumors. In short, heavy metals lead to serious illnesses and shorten our lives.

              So how does chelation impact heart health? The original theory was that EDTA chelation rids the body of calcium deposits that led to "hardening of the arteries" (or calcification)2. Some research suggested that high levels of accumulated iron in men and postmenopausal women explained their higher heart attack risk, and that removing that iron through chelation could lower that risk. 27



              When scientists began to understand the devastating effects of oxidation on the heart, chelation researchers learned that excess metals in the body encourage the production of free radicals and molecule fragments. Chelation helps reduce the levels of metals in the body, thereby reducing the production of free radicals and preventing peroxidation or breakdown of cell membranes, DNA, enzymes, and lipoproteins. Plus, reducing the free radical threat frees up the body's natural healing mechanisms, so those resources can be directed at halting or even reversing the progression of disease. 28

              Recently, researchers proposed another explanation for chelation's heart-healthy benefits. The endothelium, or lining of the arteries, produces several vital substances that reduce blood flow resistance. For example, the endothelium generates nitric oxide (NO) which causes capillary relaxation and expansion; prostacyclin, a prostaglandin which slows blood platelet aggregation and promotes vasodilation; and heparin, a natural substance with the same name as a blood-thinning drug, which prevents clotting. All these substances are critical to maintaining optimal blood circulation. But excess heavy metals in the body can diminish the endothelium's ability to produce NO, prostacyclin, and heparin-a triple whammy for your arteries. Chelation therapy can remove those heavy metals, restoring optimal production of these substances critical to cardiovascular health.

              Chelation authorities now say that the therapy's beneficial effects on blood circulation may also have positive effects on impotence, intermittent claudication, and vision problems like age-related macular degeneration and glaucoma. And new research suggests that removing heavy metals through chelation can treat and/or prevent many serious diseases, including pancreatitis, gout, both rheumatoid and osteoarthritis, chronic fatigue, irritable bowel, Alzheimer's disease, multiple sclerosis-even cancer.

              The research supporting metal toxicity's link with cancer is particularly intriguing. Several studies have linked high body iron stores with an increased risk of cancer29, particularly lung cancer30. In one study published in the New England Journal of Medicine, women with the highest iron levels31 were 50 percent more likely develop any type of cancer than women with the lowest iron levels. Chelation may reduce that risk by binding and eliminating high body iron stores
              Admin@ http://www.proactivehealthnet.com

              " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
              Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


              "The fact is that you can not start off with bad science and end up with good medicine"

              Comment


              • #8
                Because the patent for EDTA has expired, it is unlikely that any pharmaceutical company will invest the money necessary to fund studies for FDA approval of chelation therapy, despite the overwhelming evidence of its effectiveness. Robert Haskell, M.D., writes, "Of all the regimens you can use to help a patient combat degenerative disease and restore health, chelation therapy is the most powerful. It produces the greatest number of benefits to the body-far beyond those of improved blood flow. If you want to get your prescribed nutrition to those parts of the body in which they must work, chelation therapy is the way to do it."21
                Admin@ http://www.proactivehealthnet.com

                " We know that to err is human, but the HIV/AIDS hypothesis is one hell of a mistake"
                Dr. Kary Mullis, Nobel Prize Winner in Chemistry for inventing the Polymerase Chain Reaction


                "The fact is that you can not start off with bad science and end up with good medicine"

                Comment


                • #9
                  That's true. Prevention is better than cure. Better to act early than feel sorry later

                  Comment

                  Working...
                  X